NI
65
-2
CF
42
-6
PSX
29
-10
CINF
63
-3
ORLY
40
-4
ADBE
52
-4
HRL
30
-5
KHC
29
2
BDX
60
-4
JBHT
63
-2
PM
60
-2
MPC
41
-8
KSS
54
2
TXT
63
-5
TGNA
58
2
RCL
73
-3
HCA
60
-4
NEM
64
-4
RIG
35
-6
LB
22
-7
NI
65
-2
CF
42
-6
PSX
29
-10
CINF
63
-3
ORLY
40
-4
ADBE
52
-4
HRL
30
-5
KHC
29
2
BDX
60
-4
JBHT
63
-2
PM
60
-2
MPC
41
-8
KSS
54
2
TXT
63
-5
TGNA
58
2
RCL
73
-3
HCA
60
-4
NEM
64
-4
RIG
35
-6
LB
22
-7
Financhill
Back

ProShares UltraPro Short 20+ Year Treasury Vs. Nektar Therapeutics Industry Stock Comparison

Buy
77

TTT
ProShares UltraPro Short 20+ Year Treasury

Last Price:
$71.29
Seasonality Move:
8.87%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Buy
77
ProShares UltraPro Short 20+ Year Treasury (TTT) is a Buy

Is ProShares UltraPro Short 20+ Year Treasury a Buy, Sell or Hold?

  • The current ProShares UltraPro Short 20+ Year Treasury [TTT] share price is $70.89. The Score for TTT is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • TTT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TTT Stock Price Chart

What is ProShares UltraPro Short 20+ Year Treasury's stock price today?

  • The ProShares UltraPro Short 20+ Year Treasury share price today is $70.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TTT is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

TTT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.26 Buy
Relative Strength Index (14 RSI): 59.7 Buy
Chaikin Money Flow: -2508 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

TTT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.84 Buy
20-day SMA: 68.84 Buy
50-day SMA: 66.89 Buy
200-day SMA: 72.26 Sell
8-day EMA: 70.63 Buy
20-day EMA: 69.28 Buy
50-day EMA: 66.93 Buy
200-day EMA: 42.97 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

ProShares UltraPro Short 20+ Year Treasury Earnings Growth & TTT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

ProShares UltraPro Short 20+ Year Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):